Viewing Gene With Clinical Trials Data


Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/

Symbol: CHEK2
Name: checkpoint kinase 2
Location: 22q12.1
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product

Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT04190667 Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer View
NCT04508803 Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer View
NCT04712890 Determination of Prevalence and Features of HRRm mCRPC ADAM View
NCT06033092 Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion View
NCT02624973 PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial View
NCT03040791 Nivolumab in Prostate Cancer With DNA Repair Defects ImmunoProst Trial View
NCT02401347 Phase II Trial of Talazoparib in BRCA12 Wild-type HER2-negative Breast Cancer and Other Solid Tumors View
NCT05011383 High Dose Testosterone for ATM CDK12 or CHEK2 Altered Prostate Cancers View
NCT05033756 Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency COMPRENDO View
NCT05097274 The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation View
NCT03012321 AbirateronePrednisone Olaparib or AbirateronePrednisone Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects View
NCT06177171 Olaparib and ASTX727 in BRCA12- and Homologous Recombination Deficient HRD-Mutated Tumors View
NCT06392841 Niraparib Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations View
NCT03786796 Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations View
NCT04254133 Genetic Information to Inform Treatment and Screening for Prostate Cancer GIFTS Study View
NCT04265937 ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies View
NCT05787587 A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors View
NCT02952534 A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency View